Charles Pollack MD retweeted
3/8: A hierarchical #WinRatio was calculated for each plaque-based care patient vs each usual care patient for 4 outcomes, ranked by clinical priority:
Charles Pollack MD retweeted
After analyzing 2,500 angios over 2 years, I'm done. Nights, weekends—all consumed. I'm tired.
My rods & cones would like a word: They miss color. I’m trading cath lab grayscale for summer’s full palette. They miss joy. They miss art.
I want summer & paint in my eyes—not contrast and cine runs. Time to swap arteries for art. 🎨☀️ #cmgsays #cmgsees color in his future
Happy Day After Birthday @taylorswift13 ! In awe of your talent, your honesty, and your business acumen!
7
170
Need even MORE 🆓CE/#CME from expert authors right here in Twitter? From the editors of @cardiomet_ce, @ckd_ce, @onc_ce, and @pulmmed_ce, 🆕please check out (and FOLLOW!) @ibd_ce and @rheum_ce and expand your horizons!
#FOAMed #MedEd @academiccme @MedTweetorials
Who is your Twitter twin? 👯
@md_pollack = @JJheart_doc
md_pollack and JJheart_doc are Twitter twins!
#twitterTwin #toasteed
toasteed.com/dk4mr1/pdjc1syh
1
122
Charles Pollack MD retweeted
🆕🆓 #CME from @academiccme: Update on Best Practices for the Prompt and Personalized Management of Patients with #COPD Exacerbations, by William Corrao @BrighamWomens! Click on academiccme.com/courses/upda….
Salute to @GOLD_COPD! Originally presented at @EPulmonaryConf 2022.
FIRST SESSION TONIGHT!! All about #hyperkalemia from the experts, chaired by @BakrisGeorge! Don't miss it! academiccme.com/Hyperkalemia…. 🆓CE/#CME!
Attending #ACEP22? Visit the @academiccme booth today, #1539, to learn about our latest offering, an innovative ECG interpretation and acute cardiac care course originally developed in the Quebec & Montreal 🫀 Institutes! Or go to academiccme.com/ECGU/ for info and to register!
Charles Pollack MD retweeted
Great to be involved in #CardioSteps with my friend @amrelhadidyy - unfortunately this year for me will be virtual. @Hragy @aymanka @MohanedEgred @Sarah_Moharem @BassemZarif @DrAmirKaki
Charles Pollack MD retweeted
Read the 12 key points to remember about this scientific statement from the AHA for the management of patients at risk for and with left ventricular thrombus: https://nitter.cf/t.co/CxoGBhuYNU #cvACS
I am a steering committee member of SOS-AMI, a phase 3 study that has the potential to change the paradigm of AMI treatment. Talk to me at #esccongress in Barcelona if you run into me! #iampartofsosami
7
Charles Pollack MD retweeted
20) Mark your best response and RETURN TOMORROW for the correct answer and more #ERA22 data on #SGLT2i and #DKD, along with a link to your 🆓CE/#CME.
👏@ClaraGCarro @PepaSolerR @SENefrologia @JonathanNefro @nefrocat @jlgorriz @EdoardoMelilli @SVNefro @CKJsocial @torra_roser
vote!
Replying to @cardiomet_CE
19) So what have we learned?
Which of these effects, originally thought to help explain the #CV and #cardiorenal benefits of #SGLT2i, has data shown actually to be NOT so important?
a.⬆️urinary glucose excretion
b.⬆️urinary volume
c.⬆️natriuresis
d.⬇️renal vascular resistance
36%a
5%b
56%c
2%d
162 votes • Final results Charles Pollack MD retweeted
14) Taking all of this together, the renal benefits to patients with #T2D of the use of SGLT2i are obvious. Thus, @goKDIGO, @AmDiabetesAssn and @escardio @escardionews guidelines recommend its use as follows, as per a talk at #ERA22 conducted by Dr. Paola Fioretto.
FLOZINATE
Replying to @cardiomet_CE
13c)
👉alteration in intracellular sodium stores
👉⬇️uric acid
👉#RAAS modulation
Is there any doubt why "flozinating" has become so popular?!?





















